Article Information
History
- May 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Paul Elias Alexander, MSc, MHSc, PhD1,2,3,
- Joshua Piticaru, MD1,4,
- Kimberley Lewis1,2,4,
- Komal Aryal, MSc (c)1,
- Priya Thomas, BSc, MSc. (c)1,
- Wojciech Szczeklik, MD, PhD5,
- Jakub Fronczek, MD5,
- Kamil Polok, MD5,
- Waleed Alhazzani, MD, MSc, FRCPC1,4 and
- Manoj Mammen, MD, MS6,*
- 1Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main Street West, L8S4K1, Hamilton, Ontario, Canada
- 2GUIDE Research Methods Group, McMaster University, Hamilton, Ontario, Canadahttp://guidecanada.org/
- 3World Health Organization/Pan American Health Organization, consultant, Incident Management Systems for COVID-19, Washington, DC, USA, 20037
- 4Department of Medicine, McMaster University, Hamilton, Ontario Canada
- 5Department of Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland
- 6Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY
- ↵*Corresponding author: Dr. Manoj Mammen, E-mal: mammen{at}buffalo.edu
Posted May 26, 2020.
Remdesivir use in patients with coronavirus COVID-19 disease: a systematic review and meta-analysis of the Chinese Lancet trial with the NIH trial
